Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

(2011) M. E. D. Flowers et al.   BLOOD

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

(2011) J. Pidala et al.   BLOOD

The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation

(2010) S Thepot et al.   LEUKEMIA

Lung Function and Long-Term Complications after Allogeneic Hematopoietic Cell Transplant

(2009) Eric C. Walter et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD

(2009) A. C. Vigorito et al.   BLOOD

Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD

(2009) D-Y Kim et al.   BONE MARROW TRANSPLANTATION

Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy

(2008) José A. Pérez-Simón et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

New classification of chronic GVHD: added clarity from the consensus diagnoses

(2008) M Arora et al.   BONE MARROW TRANSPLANTATION

Feasibility of NIH consensus criteria for chronic graft-versus-host disease

(2008) B-S Cho et al.   LEUKEMIA